SPEAKERS

Associate Professor Ronnie Ptasznik MBBS, FRANZCR, FAIDH is the Program Director of Radiology at Monash Health, the largest Public Hospital Radiology Department in Australia. He is also an Associate Professor at the Monash University and a fellow of the Australian Institute of Digital Health.

He was the Chief Medical Information Officer at Monash Health for 7 years and during that time was the clinical lead of the EMR Implementation project . He is currently both the Chair of the Clinical design committee and a member of the steering committee for the Victorian Department of  Health Information Exchange. He has been an advisor to both state and Federal Governments in Digital health.

He is a member of the Federal Medical Advisory Board of Avant , Australia’s largest Medical Indemnity Provider.

He is interested in leveraging novel technology to decrease clinical risk , while optimising department productivity and efficiency.

Dr. Anke Diehl serves as Chief Transformation Officer at Universitätsmedizin Essen (UME), where she leads the institution’s digital transformation strategy. She sits on the German Medical Association’s  digitalization committee and represents Health-IT users on the National Interop Council, positions that place her at the intersection of clinical practice, technology standards, and national health policy. Dr. Diehl is consortial leader of the SmartHospital.NRW consortium, driving collaborative digital innovation across hospitals in North Rhine-Westphalia, and is closely engaged with Germany’s evolving digital health landscape, including the “Gemeinsam Digital 2026” strategy and EU regulatory frameworks such as the EHDS and AI Act. Dr. Diehl is a frequent voice on hospital digitalization and digital sovereignty in German healthcare.

Prof. Dr. Edson Amaro Jr is the head of Global Advanced Technologies for Equity and Full Professor in Health Data Analytics

at Albert Einstein Hospital. He is a medical doctor with a a PhD in neuroimaging (fMRI), was a Wellcome Trust Fellow at the Institute of Psychiatry, King’s College London from 2000 to 2002 and head of the Brain Institute of Albert Einstein Hospital from 2008 to 2012.

He pioneered fMRI methods in Brazil while at University of São Paulo Medicine School in which he currently holds a part-time Associate Professor position. He was in charge or creating the Big Data and Advanced Analytics areas of Albert Einstein Hospital in 2015 and was the head of the area until 2023 before accepting the current role as head of the e.Gate initiative. He continues to work in neuroradiology and has co-authored more than 250 peer-reviewed scientific papers.

Fabrice Degenève is General Manager for Johnson & Johnson Surgery Mid-Sized Markets, leading Johnson & Johnson MedTech Surgery activities across 13 markets. Since joining Johnson & Johnson in France in 1999, he has built a career focused on shaping healthcare ecosystems, accelerating innovation, and improving patient outcomes across diverse healthcare environments.

In his current role, Fabrice focuses on helping health systems respond to rapidly evolving customer needs, including the growing demand for digital innovation, personalized care, and more agile models of collaboration. He is committed to expanding the role of MedTech beyond medical devices by partnering with hospitals to unlock new sources of value, support surgeons more effectively, and advance clinical outcomes for patients.

Before this role, Fabrice served as Managing Director for Johnson & Johnson MedTech Benelux. During his tenure, he strengthened awareness and dialogue around value-based healthcare in Belgium, engaging more than 200 healthcare stakeholders and contributing to a shared set of recommendations to support a more sustainable and outcomes-driven healthcare vision.

Earlier in his career, Fabrice led initiatives in electrophysiology across the Nordic countries. He established The Nordic EP Symposium, an educational forum dedicated to advancing atrial fibrillation care that remains a pivotal event more than a decade later. He also developed a close partnership with KTH Royal Institute of Technology in Stockholm to promote emerging talent and research and initiated the first EMEA pilot exploring early diagnosis for atrial fibrillation patients through an external partnership in Finland.

Fabrice holds a master’s degree in business administration from the University of Orléans in France and completed The Leadership Transition executive program at INSEAD in 2022.

Fun fact: Fabrice reached Everest Base Camp in 2019 with the Belgian track and field Olympic team.

PERSONAL AND ACADEMIC INFORMATION

Degree: Law at Pontifícia Universidade Católica Rio de Janeiro  

Other Titles and Certifications: Advanced Management Program at 

Harvard Business School

Previous Experiences: Board member at CCR S/A, CEO at Varig S/A, Consultancy partner, CEO at Brasil Telecom, Retail VP at Shell

Awards and Recognitions: 2010 – Healthcare CEO Brasil of the Year

Additional Information: VP National Hospitals Association

CONTRIBUTIONS TO THE HOSPITAL

Innovation and projects:  Safety management system and culture, process improvement, portfolio diversification, innovation, particularly deep tech

Impact and results: development of Einstein’s position as a global leader in healthcare, innovation and research 

VISION AND FUTURE TARGETS  

Objectives for the future: Better quality and cost-efficient care for all

Citation or Personal philosophy: If it’s worth doing, it should be well done 

Sidney Klajner M.D. is a practicing General and Colorectal surgeon and President
of Einstein Hospital Israelita since 2016.
Einstein is a Healthcare System, a jewish organization, based in São Paulo, Brazil
and currently is the 16th Best Hospital in The Neewsweek Ranking.
He has led the digital health transformation at Einstein, driving innovation
through cutting-edge software, process digitization, and data-driven technologies
in both private and public sectors.
In 2019, he published the book “The Digital Revolution in Healthcare” (Editora dos
Editores).

Eliézer Silva is Director of the Einstein Health System, where he leads the integration of public and private care models and the institution’s growth and sustainability strategy. A physician with a PhD in Infectious Diseases (UNIFESP) and the title of Livre-Docente (USP), he completed postdoctoral research at the University of Colorado and executive education at Harvard Business School, Insper, and Fundação Dom Cabral. With Einstein since 1997, he has held multiple clinical and executive leadership roles. He also serves as Chairman of the Board of MedSênior and a Board member of RaiaDrogasil and Gênesis.

Profile summary
• Managing Director & Senior Partner, Paris office — BCG Social Impact & Global Health sector
lead (global) and BCG X
• Core member of BCG’s Global Health Practice, working for international institutions across
coalition governance, funding architecture and health systems transformation
• Deep experience working with WHO, Global Fund, UNITAID, Gates Foundation and major
biopharma players
Relevant BCG and BCG X experience – Social Impact, Global Health & AI
• Led BCG support to ACT-Accelerator (WHO, Unitaid, BMGF, Wellcome, Global Fund, FIND) —
vaccines, treatments, diagnostics access + COVAX dose-sharing mechanism design
• Drove strategy & transformation for UNITAID (2015 & 2021) and Global Fund (TB, malaria,
HIV) with in-country deep dives in Senegal, Kenya, Uganda
• Co-developed Immunization 2030 global strategic plan in support of WHO, and Every Woman
Every Child (PMNCH)
• Design and implementation of Lighthouse: high-frequency AI platform for demand
forecasting, field force deployment and capacity management at biopharma & MedTech
clients
• Developed AI-based patient finder tools to match patients to optimal therapies — oncology,
hematology
• Designed predictive tool to optimize hospital resource allocation during COVID-19
Education
• ESCP Europe — Master in Business (2007)

Professor Lawrence Rudski (MD FRCPC) is the inaugural director of the Azrieli Heart Centre at the Jewish General Hospital -McGill University, leveraging a unique integrated care model to deliver exceptional patient centered and value-based care. An internationally recognized leader in imaging, he has served on numerous international boards and published 150 works with over 35,000 citations. 

As the Strategy Director for Virtual Care, he developed a vision for a system-wide virtual care program and co-created a leading Hospital@Home program combining cutting edge technology with a human touch. His writings include unique concepts around combining first principles, math and physics applied to medicine, from the individual patient to systems of care, with a focus on lessons on leadership.

Louise Missault is Chief of Staff to the CEO, at the Maria Middelares hospital in Belgium, where she leads Organic Innovation initiatives focused on transforming ideas into scalable solutions with long-term patient and economic value. She is responsible for shaping and implementing the hospital’s Innovation & AI roadmap, and fostering a culture that enables innovation to thrive across the organization.

Prior to joining Maria Middelares, Louise was a Manager at McKinsey & Company in the Healthcare & Life Sciences practice, advising healthcare providers, public health institutions, and life sciences companies on strategy, transformation, and innovation.

Earlier in her career, she scaled a digital health startup from inception to rapid growth, gaining firsthand experience in healthcare entrepreneurship.

Louise holds a Master’s degree in Biomedical Engineering from Ghent University and a Master’s degree in General Management from Vlerick Business School.

Alan J. Forster MD, FRCPC, MSc is the Vice President, Innovation, Transformation, and Clinical Performance at the McGill University Health Center and the McGill University Professor for Health Innovation.

His focus is enabling teams to create higher value health care – in which patient outcomes are realized and health system costs are lowered.  

Over his career, he has led local, national, and international efforts to improve healthcare quality.  His research programs have contributed to over 240 publications in peer review journals and innumerable advances in quality.  Lasting contributions include his impact on the development of a model for learning health systems leveraging healthcare data.  

In recognition of his contributions, he was listed as one of Canada’s top 10 healthcare power brokers by Maclean’s Magazine in April 2023 and named to the International Society for Quality in Healthcare’s International Academy for Quality and Safety in Healthcare in July 2023.    

Dr Richard Bowry is Vice President, Medical Affairs, Research and Education at North York General Hospital (NYGH), where he is a member of the Senior Leadership Team and leads an integrated portfolio spanning medical affairs, education and research. He joined NYGH in 2012 as an Active Staff member of the Department of Anaesthesia and has since held several senior leadership roles, including Chief of Anaesthesia, Chair of the Credentials Committee and Vice Chair of the Medical Advisory Committee.

Dr Bowry completed his anaesthesia training in the United Kingdom in 2004 before moving to Toronto to pursue his clinical interests in cardiovascular anaesthesia and critical care. From 2004 to 2012, he worked at St Michael’s Hospital, where he held leadership roles including Director of the Cardiovascular Fellowship Program and Medical Director of the Cardiovascular Intensive Care Unit.

He has also led significant health system quality improvement work. As Medical Director of the Corporate Patient Flow Portfolio at St Michael’s Hospital, he led a multidisciplinary team focused on improving emergency wait times; this work achieved national recognition through the 3M Health Quality Team Award. In 2011 and 2012, he served as a Medical Consultant to the Health Quality Branch of Ontario’s Ministry of Health and Long-Term Care during the implementation of the Excellent Care for All Act and Quality-Based Procedures.

Dr Bowry is an Associate Professor at the University of Toronto Temerty Faculty of Medicine, promoted in 2012 for Teaching and Creative Professional Activity. He has been actively involved in teaching residents and fellows, research, medical staff governance and clinical quality. In 2024, he was appointed to the Premises Inspection Committee at the College of Physicians and Surgeons of Ontario.

Dr. David M. Kaplan is a distinguished physician-leader with over 23 years of experience at the intersection of clinical practice, health policy, and digital innovation. David is an Associate Professor at the Joint Centre for Bioethics and Temerty Faculty of Medicine at the University of Toronto; he is a leading voice in system-wide healthcare transformation. David has been instrumental in the design and implementation of hospital-based quality programs and the development of rigorous clinical & quality standards that drive clinical excellence. Currently, he also serves as Vice-President of Quality at Ontario Health.  A pioneer in digital health integration, he led the creation of Ontario’s guidance for virtual primary care and the Evidence2Practice program in primary and acute care. His work focuses on leveraging data-driven insights to enhance patient safety, clinical outcomes, and the sustainability of health care across Canada. 

Professor Gregory Katz is Chair of Value-Based Health Care at Université Paris Cité School of Medicine. A member of the French National Academy of Surgery, he focuses his research on Patient-Reported Outcome Measures (PROMs) and the role of peer benchmarking in driving continuous improvement. He sits on the medical expert board of the Statista-Newsweek World’s Best Hospitals ranking. Gregory Katz has served as Chief Scientific and Innovation Officer at major European hospital groups. He is currently the President of PromTime, a health data science company specializing in implementing Value-Based Health Care and peer benchmarking. PromTime works with payers, regulators, patient associations, and medical specialty organizations to support PROM adoption and professional self-regulation.

Senior Fellow at the Center for Patient-Oriented Health Outcomes Research (CPCOR) at Charité Universitätsmedizin Berlin and Professor of Hospital Management and Value-based Healthcare at Technical University Berlin. Board member of ICHOM. 

Experienced healthcare executive with over 25 years in leadership roles. Former CEO and Chief Medical Officer of RoMed Kliniken (>1,000 beds), CEO of Schoen Kliniken (4,800 beds), and Executive Director at The Boston Consulting Group. Founding President of ICHOM and faculty member at Harvard Business School. Expert in value-based healthcare with teaching positions at leading international institutions.

Dr. Stephen Klasko is a pioneering healthcare innovator bridging traditional academic
medicine with generative AI, digital medicine, and entrepreneurship. His transformative
career includes serving as dean of two medical colleges, health system CEO, and
university president. Recognized as the #2 most influential individual in healthcare by
Modern Healthcare, one of the “top 25 most creative people in business” by Fast
Company, and “entrepreneur of the year” by Ernst and Young, In his current roles at
General Catalyst, Sheba and DocGo, Dr. Klasko consistently drives revolutionary change
in healthcare and higher education, positioning him as a visionary leader at the
intersection of medicine, technology, and innovation.

Alan Dubovsky is the Vice President and Chief Patient Experience Officer for Cedars-Sinai in Los Angeles, California. 

 He is responsible for all patient experience improvements, and also leads the departments of Interpretation Services, Patient Advocacy, and Lobby Services. 

Alan leads the international Patient Experience efforts for Cedars-Sinai, taking the successes of the Cedars-Sinai program to international audiences and fostering best-practice sharing around the world. 

 Alan joined Cedars-Sinai in November, 2016, and has over 20 years of healthcare experience. He completed his undergraduate degree in Business Administration at the University of Georgia and his Executive Master in Business Administration at Emory University. 

Dr. David Berger is currently the US Head of Business Development & Strategy, at the Resilience & Health Innovation Hub in Sderot.  Dr. Berger is a native of New York, where he received his medical degree from the State University of New York Health Science Center at Brooklyn.  Dr. Berger completed a General Surgery residency at SUNY-Brooklyn and fellowship in Surgical Oncology at the UT MD Anderson Cancer Center.  Dr. Berger completed a Master of Science in Health Care Management at Harvard University in 2007.  Dr. Berger has over 200 publications and is Past President of two national academic surgical societies.  He is a member of the medical honor society Alpha Omega Alpha.  Dr. Berger previously served as Operative Care Line Executive at the Michael E. DeBakey VAMC, CMO, CCO, and COO at Baylor St. Luke’s Medical Center, and CEO at University Hospital at Downstate Health Sciences University.

Currently Dr. Berger is a digital health advisor — helping early-stage startups and healthcare investors navigate the complexity of building and scaling in the healthcare system. With 30+ years of leadership experience in care delivery, he works with founders and VCs to bring clinically sound, operationally feasible innovation to market.  

Graduate of Sciences Po Bordeaux and the School of Advanced Studies in Public Health. 

Served as finance director starting in 1999 at the La Roche-sur-Yon, Rochefort hospital centers, as well as the Nantes and Bordeaux university hospitals. 

Appointed Deputy Director General of the Toulouse university hospital in 2017. 

Appointed CEO of Montpellier University Hospital in 2023, where she has championed 2 key strategic priorities: 

• an ambitious hospital transformation program worth over €1 billion, aimed at modernizing hospital infrastructure;
• expanding healthcare, education, and research services by integrating AI into daily practices.

She advocates for systemic transformation while ensuring social acceptance and economic sustainability, thereby preserving the human-centric ethos.

Dr Martin Siess has served as Chief Executive Officer and Chief Medical Officer of TUM University Hospital in Munich, Germany, since July 2021. Prior to this appointment, he spent more than eleven years as Chief Medical Officer and a member of the Executive Board of University Medical Center Goettingen.

Before joining the Executive Board, Dr Siess worked for nearly five years at the international strategy consultancy Booz & Company. As a member of the firm’s management team, he advised numerous healthcare organisations in Europe and abroad on strategic and organisational matters.

Earlier in his career, he held a position in the Medical Directorate of a university hospital and worked as a physician in patient care. Dr Siess is a board-certified medical specialist and studied medicine and business administration in Munich.

Elsy advises biotech and health-tech CEOs as well as VC and PE firms. She has far-reaching expertise within the pharma and medtech industries, ranging from corporate strategy, fundraising and M&A to organization transformation, and research & development. 

Elsy is an Independent Director of  several health-tech companies, notably TreeFrog Therapeutics (Chair of the Board), GenSight Biologics, Noa Therapeutics, Inpart, and Womed. Outside of healthcare, Elsy is an Independent Director at FTI Consulting, NYSE-listed expert consultancy firm.
Previously Elsy was Executive Vice President, Chief Operating Officer at Cellectis, and prior to that a Partner and MD at The Boston Consulting Group.

Since 2024, Tue David Bak has been CEO of Innovation Skane, the leading Swedish innovation hub specializing in healthcare, AI and mobility.    

 Tue has spent the past two decades working on innovation in both the public and the private sector. He has managed projects and advised governments and business leaders in more than 25 countries in the Americas, Europe, Africa, The Middle East and Asia within healthcare, Life Science, FoodTech, entrepreneurship and finance. His clients and employers include the Danish Government, the UN, the World Bank, BSR-Business for Social Responsibility, AngloGold Ashanti, the Government of Serbia, the Government of Ghana, Region Zealand, and the Confederation of Danish Industry.

From 2017 to 2020 Tue was Executive Director at Innovation Centre Denmark in Tel Aviv, where he helped foster novel innovation alliances between the Nordics and Israel within healthcare. 

 Since 2024 Tue has overseen a portfolio of 30+ innovation projects within healthcare including hospital@home, healthcare innovation management, building an innovation hospital and innovation in healthcare procurement.     

 Tue holds a M.Sc. in Political Science and International Relations from the University of Copenhagen, Denmark. In addition, he has partaken in Executive Education in leadership and innovation management at Harvard, Univ. of Pennsylvania, U.C. Berkeley and the Technical University of Denmark.

 Tue David Bak (55) is a citizen of Denmark. He lives in Copenhagen with this wife

and two children. In his free time Tue is a vivid cyclist and skier.

Nathaniel (Nat) Sims, MD is a cardiac anesthesiologist at Massachusetts General Hospital, Associate Professor at Harvard Medical School, and holder of the Ronald S. Newbower/Eitan Endowed Chair in Biomedical Technology Innovation. For more than 40 years, he has advanced patient safety through clinician-driven innovation, pioneering technologies including the first smart drug infusion pumps and the Safe Label System. An ATP-rated pilot and FAA Wright Brothers Master Pilot Award recipient, Dr. Sims applies aviation human factors and high-reliability organization (HRO) principles to healthcare, leading interdisciplinary teams that have transformed medication safety, workforce performance, and technology commercialization.

Naomi Huck Ananou is a lawyer by training, with an unconventional path. After studying law in Montreal, she specialized in international taxation at Lyon III, then in entrepreneurship at HEC Paris, before practising with KPMG in Montreal and New York. Back in her hometown, she teaches ethics, governance, and business law at HEC Montréal. When her mother was diagnosed with digestive cancer, her commitment took on a new and deeply personal meaning, and it led her to the Institut du cancer de Montréal, affiliated with the CRCHUM, the research centre of the largest hospital network in Quebec. She joined first as Director of Major and Planned Gifts and is today its President and Chief Executive Officer. She champions one simple conviction, that health philanthropy is not charity but a strategic investment, and she works to make the Institute a neutral bridge between Montreal’s major research networks so that science reaches patients faster.

Dr. Dulchavsky is currently a professor of surgery, molecular biology and genetics at Wayne State University School of Medicine and Michigan State University. He serves as the Roy D. McClure Chairman of Surgery and the Surgeon in Chief at Henry Ford Health System in Detroit, Michigan. He is the founder and CEO of the Innovation Institute at Henry Ford. He has formed a number of successful companies in the medical device and software industry and manages multiple innovation grants.

Dr Dulchavsky completed a PhD in Molecular Biology and Genetics at Wayne State University where he investigated the use of gene therapy to improve wound healing in disease states. He has served as research mentor to over 20 post-doctoral fellows and is a principal investigator for NASA and for the National Space Biomedical Research Institute in Houston, Texas. His research focus involves teaching ultrasound to the astronaut and cosmonaut crews of the International Space Station to use for medical emergencies and on medical care for exploration class spaceflight. This work has been modified for use on the Earth where his team supports the on-site care of professional sports teams and United States Olympic Committee.  His team is working with worldwide organizations to enhance point of care ultrasound in underserved areas thru remote ultrasound guidance and to support maternal care in over 60 countries.

Dr. Dulchavsky has been elected to numerous professional organizations and national positions. He is a reviewer and the Study Section Head of the National Institutes of Health-National Institute of Biomedical Imaging and Bioengineering Study Section for International Space Station research. He maintains an active role in local and National medical associations including the American College of Surgeons where he served on the Committee on Trauma and is the Vice Chair for Technology and Research. He is on the White House Medical Team and provides regional care for the President of the United States.

Thomas Gudermann is Dean of the Faculty of Medicine of LMU Munich and Chairman of the Executive Board of M1 – Munich Medicine Alliance, a close strategic partnership of both Munich universities, university hospitals, and Helmholtz Munich. By training he is a physician and Professor and Chair of Pharmacology and Toxicology. His research focuses on molecular pharmacology, specifically on cellular signal transduction. Since 2009 he is member of the German National Academy of Sciences Leopoldina.

Melissa Cohen is a startup operator and investor. She is currently Executive in Residence at Boston Medical Center and a Venture Partner at Portal Innovations. Previously she founded and ran a venture fund inside a health system, served as Chief Innovation and Transformation Officer at a rural health system, and built a company from seed to exit. She holds an MBA from the Wharton School and teaches venture investing and entrepreneurship at Cornell’s SC Johnson College of Business

Charles N. Kahn III is a visiting senior fellow at the American Enterprise Institute and KFF, and a nonresident senior scholar at USC’s Schaeffer Center for Health Policy & Economics. He co-chairs the international Future of Health collaborative. He served 24 years as president and CEO of the Federation of American Hospitals and, earlier, as president and CEO of the Health Insurance Association of America. He had a lengthy career on Capitol Hill, including as staff director of the House Ways and Means Health Subcommittee, where he helped write HIPAA. He hosts the podcast KFF’s the Business of Health Care with Chip Kahn.

Avner Shahal is Managing Director of the Charité BIH ARC Innovation Center at Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH). Holding degrees in Psychology and Human Factors, he leads the development of innovation ecosystems that connect healthcare, research, entrepreneurship, and industry to accelerate the
translation of medical innovations into patient care. He has led technology spin-oJs and developed and patented solutions based on academic research that were successfully translated into products. His research focuses on user-specific systems, error
management, and psychological safety, and his work has appeared in peer-reviewed scientific journals and in the Harvard Business Review.

COMING SOON!

COMING SOON!

COMING SOON!